https://www.selleckchem.com/pr....oducts/a-1155463.htm
When patients with sickle cell disease have appropriate indications, they can be prescribed hydroxyurea (HU) and deferasirox (DFX) concurrently despite little knowledge about how the two medications interact. We wished to analyze whether there was evidence of adverse interaction between HU and DFX when taken simultaneously and hypothesized that those who took both drugs together had similar clinical complications when compared to those who took only one or neither drug. We conducted this retrospective cohort investigation between 2009
Curtir
Comentario
Compartilhar
